Latest News & Features
Americas
The US Court of Appeals for the Federal Circuit has affirmed a district court’s patent ruling in favour of global pharma company Endo and Scotland-based Strakan International in a case against Actavis. 17 October 2016
Americas
Mexico has introduced new rules for labelling alcoholic beverages in an effort to fight abuse of the ‘demon drink’, as Daniel Sanchez and Victor Ramirez of Olivares report. 17 October 2016
Asia
There is some debate among Russian legal professionals about whether “selection inventions” are considered patentable, but the answer seems clear, says Valery Djermakian of Gorodissky & Partners. 17 October 2016
Americas
Amgen has filed a complaint against Apotex for allegedly infringing a patent centring on Sensipar tablets. 14 October 2016
Americas
The Massachusetts Institute of Technology has succeeded in a patent infringement case against Shire Pharmaceuticals. 14 October 2016
Africa
‘Technological intelligence’ is very important for extracting maximum value from technology transfer deals, and life sciences companies should use it to their advantage, says Montserrat González-Álvarez of Leyva, Montenegro, Trigueros Abogados. 14 October 2016
Big Pharma
The EU General Court’s decision in September to fine Lundbeck nearly €150 million over several pay-for-delay deals will encourage the European Commission to take further action against similar agreements, say Bernd Allekotte and Franz Zimmer of Grünecker. 14 October 2016
Big Pharma
Pfizer has lost a battle against Actavis in a second medical use patent case centring on the drug Lyrica. 13 October 2016
Big Pharma
The English High Court has ruled on a competition case between NHS England and Servier, holding that Servier should be granted permission to re-amend its defence. 13 October 2016
Biotechnology
New legislation in Brazil aims to create a balance between using genetic resources for scientific advancement and spreading the benefits among local communities fairly, as Gabriel Di Blasi of Di Blasi, Parente & Associados and Eduardo Emrich of Biominas Brasil explain. 13 October 2016